BRPI0810159A2 - Método para tratar um distúrbio da respiração relacionado com o sono em um paciente - Google Patents

Método para tratar um distúrbio da respiração relacionado com o sono em um paciente

Info

Publication number
BRPI0810159A2
BRPI0810159A2 BRPI0810159-0A2A BRPI0810159A BRPI0810159A2 BR PI0810159 A2 BRPI0810159 A2 BR PI0810159A2 BR PI0810159 A BRPI0810159 A BR PI0810159A BR PI0810159 A2 BRPI0810159 A2 BR PI0810159A2
Authority
BR
Brazil
Prior art keywords
sleep
treat
patient
breathing disorder
related breathing
Prior art date
Application number
BRPI0810159-0A2A
Other languages
English (en)
Inventor
Dean A Handley
Larry W Hardy
Merdad Varizi Parsey
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of BRPI0810159A2 publication Critical patent/BRPI0810159A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/10—Preparation of respiratory gases or vapours
    • A61M16/14—Preparation of respiratory gases or vapours by mixing different fluids, one of them being in a liquid phase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0810159-0A2A 2007-04-09 2008-04-08 Método para tratar um distúrbio da respiração relacionado com o sono em um paciente BRPI0810159A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92246607P 2007-04-09 2007-04-09
PCT/US2008/004508 WO2008124128A2 (en) 2007-04-09 2008-04-08 Methods and compositions comprising desvenlafaxine or duloxetine for treating sleep-related breathing disorders

Publications (1)

Publication Number Publication Date
BRPI0810159A2 true BRPI0810159A2 (pt) 2014-12-30

Family

ID=39831524

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0810159-0A2A BRPI0810159A2 (pt) 2007-04-09 2008-04-08 Método para tratar um distúrbio da respiração relacionado com o sono em um paciente

Country Status (15)

Country Link
US (3) US20080293823A1 (pt)
EP (2) EP2142183A2 (pt)
JP (1) JP2010523662A (pt)
KR (1) KR20100015923A (pt)
CN (1) CN101686955A (pt)
AR (1) AR065989A1 (pt)
AU (1) AU2008236624A1 (pt)
BR (1) BRPI0810159A2 (pt)
CA (1) CA2683697C (pt)
IL (1) IL201430A0 (pt)
MX (1) MX2009010805A (pt)
NZ (1) NZ580250A (pt)
RU (1) RU2009141168A (pt)
TW (1) TW200901956A (pt)
WO (1) WO2008124128A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120101588A (ko) * 2010-01-07 2012-09-13 비버스 인크. 탄산탈수효소 억제제 및 추가적인 활성제의 조합에 의한 폐쇄 수면 무호흡 증후군의 치료
WO2011155797A2 (ko) * 2010-06-10 2011-12-15 동아제약 주식회사 결정형 오-데스메틸벤라팍신의 헤미옥살레이트염, 그의 제조방법 및 그의 약제학적 조성물
US11911351B2 (en) 2018-01-30 2024-02-27 Apnimed, Inc. (Delaware) Methods for treating sleep apnea with combinations of atomoxetine and (R)-oxybutynin
MX2021009407A (es) * 2019-02-08 2021-09-10 Brigham & Womens Hospital Inc Métodos y composiciones para el tratamiento de la apnea del sueño.

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172896A (en) 1978-06-05 1979-10-30 Dainippon Pharmaceutical Co., Ltd. Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same
US5803066A (en) * 1992-05-07 1998-09-08 New York University Method and apparatus for optimizing the continuous positive airway pressure for treating obstructive sleep apnea
GB9217295D0 (en) 1992-08-14 1992-09-30 Wellcome Found Controlled released tablets
US5541231A (en) 1993-07-30 1996-07-30 Glaxo Wellcome Inc. Stabilized Pharmaceutical
GB9315856D0 (en) 1993-07-30 1993-09-15 Wellcome Found Stabilized pharmaceutical
US5358970A (en) 1993-08-12 1994-10-25 Burroughs Wellcome Co. Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
US6150396A (en) * 1997-03-07 2000-11-21 Eli Lilly And Company Methods of treating or preventing interstitial cystitis
WO1999038504A1 (en) 1998-01-29 1999-08-05 Sepracor Inc. Pharmaceutical uses of optically pure (-)-bupropion
US7160898B2 (en) * 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
DK1466889T3 (da) * 1999-04-06 2008-09-08 Sepracor Inc O-Desmethylvenlafaxin-succinat
WO2000076955A1 (en) * 1999-06-15 2000-12-21 American Home Products Corporation Enantiomers of o-desmethyl venlafaxine
US7355042B2 (en) * 2001-10-16 2008-04-08 Hypnion, Inc. Treatment of CNS disorders using CNS target modulators
CA2556450C (en) * 2004-02-17 2013-08-06 Transoral Pharmaceuticals, Inc. Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
US20060039867A1 (en) * 2004-08-20 2006-02-23 Cypress Bioscience, Inc. Method for treating sleep-related breathing disorders with setiptiline
CA2590802A1 (en) * 2004-12-20 2006-06-29 Collegium Pharmaceutical, Inc. Pharmaceutical compositions for sleep disorders
JP5197361B2 (ja) * 2005-06-06 2013-05-15 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティー オブ イリノイ 睡眠障害を処置するための組成物および方法
WO2007026219A2 (en) * 2005-08-31 2007-03-08 Pfizer Products Inc. Combinations of a 5-ht1b antagonist with a noradrenalin re-uptake inhibitor or a serotonin noradrenalin reutake inhibitor for treating cns conditions
BRPI0807604A2 (pt) * 2007-02-21 2014-07-22 Sepracor Inc Composto, composição farmacêutica, e, métodos para tratar, prevenir ou controlar deprressão, dor, ansiedade, e incontiência
US20090048233A1 (en) * 2007-08-16 2009-02-19 Cypress Biosciences, Inc. Enhancing the Tolerability of a Seratonin Antagonist and a NSRI, a SNRI or a RIMA by Using Them in Combination

Also Published As

Publication number Publication date
EP2142183A2 (en) 2010-01-13
AU2008236624A1 (en) 2008-10-16
RU2009141168A (ru) 2011-05-20
CA2683697C (en) 2016-08-16
EP2455076A1 (en) 2012-05-23
US20080293823A1 (en) 2008-11-27
WO2008124128A2 (en) 2008-10-16
US20150196531A1 (en) 2015-07-16
CA2683697A1 (en) 2008-10-16
WO2008124128A3 (en) 2009-05-07
TW200901956A (en) 2009-01-16
IL201430A0 (en) 2010-05-31
NZ580250A (en) 2012-05-25
KR20100015923A (ko) 2010-02-12
US20120238616A1 (en) 2012-09-20
MX2009010805A (es) 2009-10-29
JP2010523662A (ja) 2010-07-15
AR065989A1 (es) 2009-07-15
CN101686955A (zh) 2010-03-31

Similar Documents

Publication Publication Date Title
BRPI0920196A2 (pt) métodos e dispositivos para tratamento da apnéia do sono
BRPI0811845A2 (pt) Forma de dosagem, e, métodos de preparação da forma de dosagem, e de tratamento de uma má condição em um paciente
GB2465897B (en) Respiratory disease treatment
BR112012005398A2 (pt) dispositivo implantável, e, método para administrar lidocaína na bexiga de um paciente
BRPI0915476A2 (pt) dispositivo para tratar problemas respiratórios
BRPI1013089A2 (pt) alimento medicinal, e, métodos para preparar um alimento medicinal, e para tratar um distúrbio metabólico
BRPI0919961A2 (pt) sistema e métodos de implante para tratamento da apneia obstrutiva do sono
BRPI0822374A2 (pt) aparelhos e métodos para avaliar uma pessoa para um sistema de sono
EP2222359A4 (en) DEVICES AND METHOD FOR TREATMENT OF BREATHING IN SLEEP
BRPI0819630A2 (pt) Montagem de interface de paciente para terapia respiratória
BRPI0907439A2 (pt) Derivado de carboxamidas azabiciclicos, o respectivo preparo e a respectiva aplicação em terapêutica
BRPI0819642A2 (pt) Método para a formação de uma dentadura para um paciente em uma única visita, e, dentadura
BRPI0916579A2 (pt) métodos e dispositivos para formar uma via aérea auxiliar para tratar apneia obstrutiva do sono
IL219945A (en) 1-GLP history with dual transduction and use of it to prepare a drug for the treatment of diabetes
IL211985A (en) Non-symmetrical pyrolobenzodiazepine dimers and their use in the preparation of a drug for the treatment of rapid culture
BRPI1010084A2 (pt) Método para tratar esclerose lateral amiotrófica em um paciente
BRPI0811844A2 (pt) Composto, e, método para tratar um paciente
BRPI0810440A2 (pt) Derivados de triazolopiridina-carboxamidas e triazolopirimidina-carboxamidas, o respectivo preparo e a respectiva aplicação em terapêutica
BRPI0918103A2 (pt) "método para o tratamento da dor em um indivíduo"
BR112012031562A2 (pt) método para tratar distúrbio de hiperatividade com déficit de atenção (adha) em um paciente
IL217198A0 (en) Composition for treating a patient in need of aspirin therapy
BRPI0906606A2 (pt) Tratamento terapêutico para condições do pulmão.
BRPI0917464A2 (pt) compostos de azetidinas polissubstituídas, o respectivo preparo e a respectiva aplicação em terapêutica
BRPI0810159A2 (pt) Método para tratar um distúrbio da respiração relacionado com o sono em um paciente
IL197125A0 (en) Drug combinations for treating airway diseases

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL